Key facts
- ArcaScience’s last known valuation is $5.4M (Jun 2023).
- It has raised $13.2M; the latest was Later Stage VC ($7.0M) in Sep 2025.
- Notable investors include Plug and Play Tech Center, Bpifrance, Kima Ventures, Hatcher+, Aglaé Ventures — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for ArcaScience
- ·The full record, as it builds
Funding rounds
No funding rounds for ArcaScience are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ArcaScience
Developer of an AI tool intended to streamline vital data and enhance clinical decision-making for true patient-centric outcomes. The company's layouts use algorithms, artificial intelligence, and a decentralised network to rationalise and interconnect scientific databases that save time in the development of research, knowledge, and valuation of the text, enabling healthcare professionals to transform complex biomedical knowledge into actionable insights, ensuring better and safer treatments for every patient
- Sector
- Information Technology
- HQ
- Paris, France
- Founded
- 2018
- Employees
- 23
- Website
- arcascience.ai/
- Ownership
- Privately Held (backing)
ArcaScience doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ArcaScience shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ArcaScience in its N-PORT filings yet. We sweep new filings monthly.